We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest Articles
What the COVID-19 Pandemic Taught Us About Flexibility in Vaccine Manufacturing
Article

What the COVID-19 Pandemic Taught Us About Flexibility in Vaccine Manufacturing

In this article, we will explore the manufacturing strategies and tools that the biopharmaceutical industry adopted to make such efficient COVID-19 vaccine production possible.
DNA Repair Hotspots and “Super-Agers”: An Interview With Fred “Rusty” Gage
Article

DNA Repair Hotspots and “Super-Agers”: An Interview With Fred “Rusty” Gage

Fred “Rusty” Gage is president of the Salk Institute for Biological Studies. After his recent plenary at the British Neuroscience Association’s Festival of Neuroscience, we spoke with Gage about his research into how our DNA repairs itself and how Alzheimer's disease causes neurons to undergo and identity crisis.
How Can We Take Advantage of Ketamine’s “Window of Opportunity?”
Article

How Can We Take Advantage of Ketamine’s “Window of Opportunity?”

At the British Neuroscience Association’s 2021 Festival of Neuroscience, a session was devoted to the discussion of new research working towards understanding ketamine’s mechanism of action and its potential use as a treatment for alcohol use disorder.
Beast Machines and Hallucination Networks: Anil Seth Discusses Consciousness at BNA 2021
Article

Beast Machines and Hallucination Networks: Anil Seth Discusses Consciousness at BNA 2021

The basis of our consciousness has perplexed experienced researchers, esteemed thinkers and the rest of humanity for several thousand years. At the British Neuroscience Association’s 2021 Festival of Neuroscience, University of Sussex Professor Anil Seth used his plenary lecture to dive deeper into new perspectives in our scientific approach to consciousness.

The Long Run: Keeping an Eye on COVID-19 Vaccines
Article

The Long Run: Keeping an Eye on COVID-19 Vaccines

In this opinion article, Michael S Kinch seeks to summarize key concerns and opportunities facing COVID-19 vaccines as we look towards the future.
Combating Challenging Separations With Advanced 2D Liquid Chromatography Technologies
Article

Combating Challenging Separations With Advanced 2D Liquid Chromatography Technologies

Liquid chromatography (LC) systems are the backbone of pharmaceutical and biopharmaceutical laboratories. However, with increasingly complex samples and efficiency pressures, scientists are seeking more confidence in their results. Can innovative two-dimensional LC (2D-LC) systems provide the answer?
Non-Invasive Biomarker Can Track and Verify Senolytic Drug Efficacy
Article

Non-Invasive Biomarker Can Track and Verify Senolytic Drug Efficacy

In a new study published in Cell Metabolism, scientists share their discovery of a novel, non-invasive biomarker test that can be utilized to measure and track the performance of senolytic drugs.
Stimulation Sensation: The Non-Invasive Technologies Shaking Up Neuroscience
Article

Stimulation Sensation: The Non-Invasive Technologies Shaking Up Neuroscience

The growing field of non-invasive brain stimulation (NIBS) is a new frontier of neuroscience. NIBS could provide therapies for psychiatric conditions without drugs or invasive surgery. In this article, we explore how brain stimulation devices are being developed everywhere from academic labs to internet message boards.
A Novel, Colloidal Form of Activated Carbon Demonstrates Effective, In-Place Removal of PFAS From Groundwater
Article

A Novel, Colloidal Form of Activated Carbon Demonstrates Effective, In-Place Removal of PFAS From Groundwater

Per- and polyfluoroalkyl substances (PFAS) are estimated to contaminate more than 200 million Americans' drinking water and have been associated with adverse health effects. Scientists, however, have devised a solution that can remove PFAS before it even leaves the ground.
Targeting the Dopamine Receptor Pathway To Treat AML
Article

Targeting the Dopamine Receptor Pathway To Treat AML

Technology Networks recently interviewed Prof. Mick Bhatia, from McMaster University, to learn more about his research focused on the role of abnormal dopamine receptor pathway activation in adult patients with acute myeloid leukemia (AML).
Advertisement